Paid Clinical Trials Fort Wayne

Discover 57 paid clinical trials in Fort Wayne, Indiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 57

VITRAKVIStudy to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body

Recruiting

Sponsor:

Bayer

Location:

Multiple Locations, Fort Wayne IN, Lansing MI, Farmington Hills MIshow 42 more

Code:

NCT04142437

Conditions

Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

larotrectinib(Vitrakvi, BAY2757556)

ABBV-383A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed or Refractory Multiple Myeloma

Recruiting

PHASE1

Sponsor:

TeneoOne Inc.

Location:

Fort Wayne IN, Cincinnati OH, Hinsdale IL, Hamiltonshow 19 more

Code:

NCT05650632

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ABBV-383

Venetoclax with cBTKiA Study to Evaluate the Effect of Venetoclax on Participants Receiving a Covalent Bruton's Tyrosine Kinase Inhibitor (cBTKi) for First-Line Chronic Lymphocytic Leukemia (1L CLL) to Achieve Deep Durable Remissions to Allow Off-Treatment Period.

Recruiting

PHASE2

Sponsor:

Genentech, Inc.

Location:

Fort Wayne IN, Columbus OH, Cincinnati OH, Nashville TNshow 15 more

Code:

NCT06524375

Conditions

Chronic Lymphocytic Leukemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Venetoclax

cBTKi Monotherapy

Biobank RegistryTEMPUS ARIES: A Biobank Registry Platform Study in Oncology

Recruiting

Sponsor:

Tempus AI

Location:

Fort Wayne IN, Goshen IN, Maumee OH, Hinsdale ILshow 20 more

Code:

NCT06207032

Conditions

Cancer

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Trastuzumab Deruxtecan & AnastrozoleTrastuzumab Deruxtecan Alone or in Combination with Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer

Recruiting

PHASE2

Sponsor:

Jonsson Comprehensive Cancer Center

Location:

Fort Wayne IN, Wichita KS, Boston MA, Orlando FLshow 5 more

Code:

NCT04553770

Conditions

Early-stage Breast Cancer

Hormone Receptor Positive Breast Carcinoma

Invasive Breast Cancer

Stage II Breast Cancer

Stage IIA Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Anastrozole

Therapeutic Conventional Surgery

Trastuzumab Deruxtecan

Nemtabrutinib vs. Ibrutinib & AcalabrutinibA Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Recruiting

PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Fort Wayne IN, Grand Rapids MI, Edgewood KY, Madison WIshow 23 more

Code:

NCT06136559

Conditions

Chronic Lymphocytic Leukemia

Small Lymphocytic Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Nemtabrutinib

Ibrutinib

Acalabrutinib

RavulizumabARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE

Recruiting

PHASE3

Sponsor:

Alexion Pharmaceuticals, Inc.

Location:

Fort Wayne IN, Indianapolis IN, Columbus OH, Detroit MIshow 43 more

Code:

NCT05746559

Conditions

Chronic Kidney Disease

CKD

Cardiac Disease

Cardiopulmonary Bypass

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Placebo

Ravulizumab

BostonGene & ExigentBostonGene and Exigent Genomic INsight Study

Recruiting

Sponsor:

BostonGene

Location:

Fort Wayne IN, Rogers AR, Tulsa OK, Houston TXshow 3 more

Code:

NCT06272864

Conditions

Breast Cancer

Non-small Cell Lung Cancer

Melanoma

Sarcoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Neoadjuvant Chemotherapy & TrastuzumabStudy of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling

Recruiting

PHASE2

Sponsor:

NSABP Foundation Inc

Location:

Fort Wayne IN, Dayton OH, Ann Arbor MI, Marion OHshow 33 more

Code:

NCT03412643

Conditions

HER2-negative Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Doxorubicin

Cyclophosphamide

Weekly Paclitaxel

Trastuzumab

Pertuzumab

BION-1301A Study of Zigakibart in Adults With IgA Nephropathy

Recruiting

PHASE3

Sponsor:

Chinook Therapeutics, Inc.

Location:

Fort Wayne IN, Cincinnati OH, Evanston IL, Hinsdale ILshow 30 more

Code:

NCT05852938

Conditions

IgA Nephropathy

Immunoglobulin A Nephropathy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BION-1301

Placebo